Enteropathogenic bacteria in dogs and cats: diagnosis, epidemiology, treatment, and control

This report offers a consensus opinion on the diagnosis, epidemiology, treatment, and control of the primary enteropathogenic bacteria in dogs and cats, with an emphasis on Clostridium difficile, Clostridium perfringens, Campylobacter spp., Salmonella spp., and Escherichia coli associated with granulomatous colitis in Boxers. Veterinarians are challenged when attempting to diagnose animals with suspected bacterial-associated diarrhea because well-scrutinized practice guidelines that provide objective recommendations for implementing fecal testing are lacking. This problem is compounded by similar isolation rates for putative bacterial enteropathogens in animals with and without diarrhea, and by the lack of consensus among veterinary diagnostic laboratories as to which diagnostic assays should be utilized. Most bacterial enteropathogens are associated with self-limiting diarrhea, and injudicious administration of antimicrobials could be more harmful than beneficial. Salmonella and Campylobacter are well-documented zoonoses, but antimicrobial administration is not routinely advocated in uncomplicated cases and supportive therapy is recommended. Basic practices of isolation, use of appropriate protective equipment, and proper cleaning and disinfection are the mainstays of control. Handwashing with soap and water is preferred over use of alcohol-based hand sanitizers because spores of C. difficile and C. perfringens are alcohol-resistant, but susceptible to bleach (1:10 to 1:20 dilution of regular household bleach) and accelerated hydrogen peroxide. The implementation of practice guidelines in combination with the integration of validated molecular-based testing and conventional testing is pivotal if we are to optimize the identification and management of enteropathogenic bacteria in dogs and cats.     

Epidemiology, diagnosis, and treatment of blastomycosis in dogs and cats

Blastomycosis is one of the most common systemic fungal diseases in dogs in North America, but it is rarely diagnosed in cats. The typical route of infection is inhalation of aerosolized conidia of Blastomyces dermatitidis. From the respiratory tract, the developing yeast form may disseminate throughout the body and affect multiple organ systems, most commonly the lymphatic, skeletal and central nervous systems, eyes and skin. Disseminated disease often is associated with nonspecific signs of illness including lethargy, inappetence and fever, as well as signs referable to specific organ systems like chronic cough and dyspnea, peripheral lymphadenopathy, endophthalmitis, and central nervous signs. Diagnosis is typically made by detection of Blastomyces dermatitidis yeast in affected tissues by fine-needle aspiration cytology or histopathology. The treatment of choice is itraconazole. Prognosis is fair in dogs without central nervous disease and guarded in cats.     

Bovine arthritides. Classification, diagnosis, prognosis, and treatment

Bovine arthritides are an important aspect of food animal practice, and a good understanding of these conditions allows the practitioner to develop effective treatment regimens. This article discusses the complexities of joint diseases and the problems associated with their diagnoses and treatments.     

Nasal tumors in the dog: retrospective evaluation of diagnosis, prognosis, and treatment

The records of 43 dogs with nasal tumors (1969- 1974) were evaluated in retrospect. The median age at diagnosis was 10 years. Most affected dogs were bloody nasal discharge, sneezing, and nasal bone deformities. A new method of obtaining tissure for cytologic and histologic evalution proved to be accurate in making a definitive diagnosis in 50% of the cases evaluated. Affected dogs were treated by surgery, surgery plus immunotherapy, or not at all. The results of those treated by surgery alone were no better than those not treated.     

Urethral obstruction in cats: predisposing factors, clinical, clinicopathological characteristics and prognosis

Feline lower urinary tract diseases in general, and urethral obstruction (UO) in particular, are common clinical conditions in cats. The aims of this study were to identify risk factors for UO, to characterise clinical and clinicopathological signs, outcome and recurrence, as well as risk factors for mortality and recurrence. Eighty-two cats with UO were compared to 82 sex and time matched controls. The mean age of cats with UO was significantly lower compared to controls, while the mean body weight was higher. The proportion of indoors-outdoors cats was significantly lower in the study group compared to the control group, and the proportion of cats consuming only dry food was higher. Overall mortality was 8.5%. Ionised calcium was significantly higher in survivors compared to non-survivors, and the prevalence of hypocalcaemia was lower. Recurrence in 6 months and 2 years were 22% and 24%, respectively. Cats with recurrence had significantly lower urine pH at presentation.     

Toxoplasmosis in cats: Diagnosis, treatment and prevention

The clinical and parasitologic features of toxoplasmosis, serologic diagnosis, treatment, transmission and prevention are discussed.     

Congenital portosystemic shunts in cats: investigation, diagnosis and stabilisation

PRACTICAL RELEVANCE: Although a relatively uncommon condition, the investigation, diagnosis and initial medical management of feline congenital portosystemic shunts is often undertaken within general practice. Early recognition and appropriate treatment are important to ensure a good outcome. CLINICAL CHALLENGES: Clinical signs associated with CPSSs in cats are extremely variable and can be intermittent. Signs can affect a variety of organ systems including the nervous system, and gastrointestinal and urinary tracts. Thus, the differential diagnosis list may be very long and a CPSS may not be suspected initially. More specific diagnostic tests and diagnostic imaging are indicated but may not be 100% accurate and may not be readily available to the general practitioner. AUDIENCE: This review highlights challenging aspects of the investigation and management of CPSSs for the practising veterinarian, but is also relevant to postgraduate students and provides a practical summary for specialists. PATIENT GROUP: In practice, domestic shorthairs make up the majority of cats with CPSSs. However, Siamese, Persian and Himalayan cats may be more commonly affected than other purebreeds. While cats with CPSSs are typically under 6 months old, the condition is seen in mature animals, which may not have exhibited clinical signs for months or years. EVIDENCE BASE: Despite several retrospective studies of cats with CPSSs, the evidence base for management of the condition remains limited.     

Congenital portosystemic shunts in cats: surgical management and prognosis

PRACTICAL RELEVANCE: Although the surgical management of feline congenital portosystemic shunts (CPSSs) is normally performed at specialist centres, a good knowledge of treatment options and prognosis is important for the general practitioner when advising clients. CLINICAL CHALLENGES: A variety of surgical techniques are described for the correction of CPSSs in cats. Choosing between the different techniques is a challenge, given the limited availability of evidence supporting one technique over another. In addition, postoperative complications, and in particular neurological complications, are seen more frequently in the cat than the dog and thus postoperative monitoring and treatment is critically important in feline patients. AUDIENCE: This article summarises current evidence in surgical management and is aimed at practising veterinarians, postgraduate students and specialists alike. EQUIPMENT: Surgical management of CPSSs typically requires advanced surgical and critical care facilities. The precise nature will depend to some extent on the technique employed. EVIDENCE BASE: The evidence base for decision making in the surgical management of CPSSs is relatively sparse. In reviewing the evidence that is available, as well as the areas in which information is still lacking, this article may hopefully serve as a stimulus for further investigation into this condition.     

Underlying cause, pathophysiologic abnormalities, and response to treatment in cats with septic peritonitis: 51 cases (1990-2001)

OBJECTIVE: To determine the underlying cause, pathophysiologic abnormalities, and response to treatment in cats with septic peritonitis and identify differences between cats that survived following treatment and cats that did not survive despite treatment. DESIGN: Retrospective study. ANIMALS: 51 cats with septic peritonitis. PROCEDURE: Medical records were reviewed for clinical findings; results of clinicopathologic testing, microbial culture, and radiography; diagnosis; treatment; and outcome. RESULTS: Signs of pain during palpation of the abdomen were reported for only 29 of 47 (62%) cats. Eight (16%) cats had relative bradycardia (heart rate < 140 beats/min). The most commonly isolated organisms included Escherichia coli, Enterococcus spp, and Clostridium spp. The most common cause of peritonitis was gastrointestinal tract leakage (24 cats). No definitive source could be identified in 7 cats. Treatment, including exploratory surgery, was pursued in 23 cats, of which 16 (70%) survived and were discharged. There were no significant differences between survivors and nonsurvivors in regard to heart rate, age, rectal temperature, serum lactate concentration, WBC count, PCV, blood glucose concentration, or serum albumin concentration. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that clinicopathologic abnormalities and outcome in cats with septic peritonitis are similar to those reported for dogs. However, certain features may be unique, including an absence of signs of pain during abdominal palpation, relative bradycardia, and apparent spontaneous peritonitis in some cats.     

Portosystemic shunts: diagnosis,prognosis, and treatment of 64 cases (1993-2001)

Cases diagnosed with portosystemic shunting between the years 1993 and 2001 were reviewed. Sensitivities of screening tests and abdominal ultrasonographic evaluation for the detection of portosystemic shunting were evaluated. Prognosis for surgically treated shunts was also evaluated. Results indicated that both paired serum bile acids and blood ammonia levels were useful screening tests for portosystemic shunting. However, paired bile acid tests were significantly more sensitive than blood ammonia levels. Overall postoperative mortality rates for extrahepatic shunts and intrahepatic shunts were 8.7% and 20%, respectively. Postoperative mortality rates were slightly higher for animals treated with partial ligation when compared to those treated with ameroid ring placement, although this did not reach statistical significance. Long-term complication rates for animals with single extrahepatic portosystemic shunts treated with complete ligation, ameroid ring placement, and partial ligation alone were 9%, 15.4%, and 42%, respectively. Animals >2 years of age with extrahepatic shunts had almost identical postoperative mortality and long-term complication rates as animals < or = 2 years of age. No animal in this study had paired bile acid samples within the reference range postoperatively, indicating continued abnormal liver function after surgery.     

Antemortem diagnosis and treatment of toxoplasmosis in two cats on cyclosporin therapy

Clinical toxoplasmosis was diagnosed antemortem in two cats being treated with therapeutic doses of cyclosporin. The diagnosis was made by detecting tachyzoites on cytological examination of bronchoalveolar lavage fluid from one case and pleural effusion from the other. Despite early diagnosis and aggressive treatment in both cases, only one cat survived. Reactivation of latent Toxoplasma gondii infection secondary to cyclosporin-induced immunosuppression was considered likely in both cases. The presence of respiratory signs in cats treated with cyclosporin should alert clinicians to the possibility of clinical toxoplasmosis. Consideration should be given to determining the serostatus of cats to T gondii prior to use of drugs which are potent inhibitors of cell mediated immunity, such as cyclosporin. Two cases of feline toxoplasmosis are presented.     

Current concepts in the diagnosis and treatment of brain tumours in dogs and cats

Intracranial tumours occur relatively frequently in dogs, and less commonly in cats. With the availability of computed tomography (CT) and magnetic resonance imaging, more accurate determination of the location and extent of brain tumours in companion animals has become possible. Following these advances in imaging, precise CT-guided stereotactic techniques for both tumour biopsy and intratumoral drug delivery have been developed for use in cats and dogs. Also, tumour identification methods, such as crush preparation examination, have facilitated rapid tumour identification. The use of improved diagnostic techniques has resulted in an increasing demand for effective therapies for brain tumours. While surgical removal and irradiation remain important treatment considerations in the management of brain tumours of cats and dogs, the development of gene therapy strategies for treatment of intracranial tumours offers much promise, although research in this area is still at an early stage.